Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Other financing activities (2024)

Abeona Therapeutics (ABEO) has 5 years of Other financing activities data on record, last reported at $963000.0 in Q1 2024.

  • For Q1 2024, Other financing activities changed N/A year-over-year to $963000.0; the TTM value through Dec 2024 reached $963000.0, changed N/A, while the annual FY2024 figure was $963000.0, 542.0% up from the prior year.
  • Other financing activities reached $963000.0 in Q1 2024 per ABEO's latest filing, down from $1.9 million in the prior quarter.
  • Across five years, Other financing activities topped out at $963000.0 in Q1 2024 and bottomed at $963000.0 in Q1 2024.